| Schedule of Revenue by Product Category |
The following table presents the Company’s
revenue by product category for the three months ended March 31, 2025, and 2024:
| | |
For the Three Months Ended
March 31, | |
| | |
2025 | | |
2024 | |
| Training | |
$ | 144,920 | | |
$ | 110,333 | |
| Product supplies | |
| 626,656 | | |
| 355,481 | |
| Equipment | |
| - | | |
| 96,810 | |
| Patient procedures | |
| 592,765 | | |
| 254,410 | |
| Total revenue | |
$ | 1,364,341 | | |
$ | 817,034 | |
|
The following table presents the Company’s
revenue by product category for the years ended December 31, 2024, and 2023:
| | |
For the Years Ended
December
31, | |
| | |
2024 | | |
2023 | |
| Training | |
$ | 809,654 | | |
$ | 599,425 | |
| Product supplies | |
| 1,748,960 | | |
| 1,329,159 | |
| Equipment | |
| 177,225 | | |
| 162,370 | |
| Patient procedures | |
| 1,371,655 | | |
| 318,999 | |
| Total revenue | |
$ | 4,107,494 | | |
$ | 2,409,953 | |
|
| Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Loss |
Listed below are the revenues, cost of revenues,
gross profits, assets and net loss by Company:
| | |
For the Three Months Ended | |
| | |
March 31, 2025 | |
| | |
Global Stem Cells Group | | |
Regenerative Medical Technology
Group | | |
Total | |
| Revenue | |
$ | 1,364,341 | | |
$ | - | | |
$ | 1,364,341 | |
| Cost of revenue | |
| 420,447 | | |
| - | | |
| 420,447 | |
| Gross profit | |
$ | 943,894 | | |
$ | - | | |
$ | 943,894 | |
| Gross Profit % | |
| 69.18 | % | |
| 0.00 | % | |
| 69.18 | % |
| | |
| | | |
| | | |
| | |
| Assets | |
$ | 2,138,933 | | |
$ | 1,841,835 | | |
$ | 3,980,768 | |
| Net profit (loss) | |
$ | 91,887 | | |
$ | (851,927 | ) | |
$ | (760,040 | ) |
|
Listed below are the revenues, cost of revenues,
gross profits, assets and net loss by Company:
| | |
For the Year Ended | |
| | |
December 31, 2024 | |
| | |
Global Stem | | |
Meso | | |
| |
| | |
Cells Group | | |
Numismatics | | |
Total | |
| Revenue | |
$ | 4,107,494 | | |
$ | - | | |
$ | 4,107,494 | |
| Cost of revenue | |
| 1,284,375 | | |
| - | | |
| 1,284,375 | |
| Gross profit | |
$ | 2,823,119 | | |
$ | - | | |
$ | 2,823,119 | |
| Gross Profit % | |
| 68.73 | % | |
| 0.00 | % | |
| 68.73 | % |
| | |
| | | |
| | | |
| | |
| Assets | |
$ | 1,951,853 | | |
$ | 1,869,576 | | |
$ | 3,821,429 | |
| Net income (loss) | |
$ | 303,730 | | |
$ | (5,866,701 | ) | |
$ | (5,562,971 | ) |
|